tiprankstipranks
Affluent Medical SA (FR:CVX)
:CVX
France Market
CVX
Affluent Medical SA
RESEARCH TOOLSreports
Want to see FR:CVX full AI Analyst Report?

Affluent Medical SA (CVX) Ratios

2 Followers

Affluent Medical SA Ratios

FR:CVX's free cash flow for Q4 2025 was €0.00. For the 2025 fiscal year, FR:CVX's free cash flow was decreased by € and operating cash flow was €0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.30 0.30 1.28 0.69 0.83
Quick Ratio
 0.30 0.30 1.28 0.69 0.83
Cash Ratio
 0.07 0.07 0.13 0.20 0.30
Solvency Ratio
 -0.54 -0.54 -0.40 -0.54 -0.49
Operating Cash Flow Ratio
 -0.49 -0.49 -1.19 -1.43 -1.28
Short-Term Operating Cash Flow Coverage
 -1.01 -1.01 -7.76 -6.91 -6.46
Net Current Asset Value
€ -35.17M€ -35.17M€ -18.43M€ -19.36M€ -19.01M
Leverage Ratios
Debt-to-Assets Ratio
 0.50 0.50 0.27 0.30 0.30
Debt-to-Equity Ratio
 4.33 4.33 0.54 0.54 0.52
Debt-to-Capital Ratio
 0.81 0.81 0.35 0.35 0.34
Long-Term Debt-to-Capital Ratio
 0.68 0.68 0.32 0.31 0.31
Financial Leverage Ratio
 8.62 8.62 2.01 1.80 1.77
Debt Service Coverage Ratio
 -1.22 -1.29 -7.11 -5.61 -4.67
Interest Coverage Ratio
 -25.77 0.00 -64.83 -33.25 -11.00
Debt to Market Cap
 0.19 0.34 0.29 0.30 0.52
Interest Debt Per Share
 0.63 0.61 0.42 0.60 1.00
Net Debt to EBITDA
 -1.41 -1.41 -1.12 -1.16 -1.15
Profitability Margins
Gross Profit Margin
-373.66%0.00%-225.16%-98.04%-82.45%
EBIT Margin
-3048.18%0.00%-384.63%-1258.01%-1169.83%
EBITDA Margin
-2740.38%0.00%-326.44%-1090.11%-986.86%
Operating Profit Margin
-3125.82%0.00%-380.99%-1067.48%-887.45%
Pretax Profit Margin
-4507.97%0.00%-390.51%-1389.71%-1150.11%
Net Profit Margin
-4327.73%0.00%-357.92%-1278.84%-1137.19%
Continuous Operations Profit Margin
-4327.73%0.00%-357.92%-1278.84%-1137.19%
Net Income Per EBT
96.00%96.00%91.65%92.02%98.88%
EBT Per EBIT
144.22%144.51%102.50%130.19%129.60%
Return on Assets (ROA)
-52.21%-52.21%-24.22%-27.64%-25.37%
Return on Equity (ROE)
-187.32%-449.85%-48.69%-49.74%-45.01%
Return on Capital Employed (ROCE)
-74.08%-73.93%-30.57%-27.11%-23.13%
Return on Invested Capital (ROIC)
-48.38%-48.28%-27.10%-23.91%-21.98%
Return on Tangible Assets
-283.47%-283.47%-109.02%-210.59%-169.26%
Earnings Yield
-20.48%-36.68%-27.75%-29.19%-47.99%
Efficiency Ratios
Receivables Turnover
 0.16 0.00 1.19 0.36 0.33
Payables Turnover
 0.45 0.36 2.83 0.72 0.81
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.38 0.00 3.30 0.77 0.76
Asset Turnover
 0.01 0.00 0.07 0.02 0.02
Working Capital Turnover Ratio
 -0.07 0.00 -8.24K -0.60 0.45
Cash Conversion Cycle
 1.53K -1.02K 176.77 506.29 652.24
Days of Sales Outstanding
 2.35K 0.00 305.70 1.01K 1.10K
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 812.54 1.02K 128.94 507.90 451.21
Operating Cycle
 2.35K 0.00 305.70 1.01K 1.10K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.30 -0.30 -0.29 -0.42 -0.59
Free Cash Flow Per Share
 -0.30 -0.30 -0.29 -0.42 -0.59
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.01 1.01 1.01 1.02 1.01
Dividend Paid and CapEx Coverage Ratio
 -100.08 -100.08 -77.03 -65.51 -75.90
Capital Expenditure Coverage Ratio
 -100.08 -100.08 -77.03 -65.51 -75.90
Operating Cash Flow Coverage Ratio
 -0.48 -0.48 -0.69 -0.70 -0.62
Operating Cash Flow to Sales Ratio
 -20.12 0.00 -2.75 -9.85 -8.28
Free Cash Flow Yield
-9.63%-17.22%-21.60%-22.82%-35.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -4.84 -2.73 -3.60 -3.43 -2.08
Price-to-Sales (P/S) Ratio
 208.89 0.00 12.90 43.81 23.70
Price-to-Book (P/B) Ratio
 21.76 12.26 1.75 1.70 0.94
Price-to-Free Cash Flow (P/FCF) Ratio
 -10.28 -5.81 -4.63 -4.38 -2.83
Price-to-Operating Cash Flow Ratio
 -10.40 -5.86 -4.69 -4.45 -2.86
Price-to-Earnings Growth (PEG) Ratio
 0.07 -0.04 0.11 0.10 -1.67
Price-to-Fair Value
 21.76 12.26 1.75 1.70 0.94
Enterprise Value Multiple
 -9.03 -5.72 -5.07 -5.18 -3.55
Enterprise Value
 144.00M 90.37M 68.22M 69.10M 46.88M
EV to EBITDA
 -9.11 -5.72 -5.07 -5.18 -3.55
EV to Sales
 249.57 0.00 16.57 56.46 35.01
EV to Free Cash Flow
 -12.28 -7.71 -5.95 -5.65 -4.18
EV to Operating Cash Flow
 -12.40 -7.78 -6.02 -5.73 -4.23
Tangible Book Value Per Share
 -0.85 -0.85 -0.43 -0.61 -0.91
Shareholders’ Equity Per Share
 0.14 0.14 0.77 1.09 1.79
Tax and Other Ratios
Effective Tax Rate
 0.04 0.04 0.08 0.08 0.01
Revenue Per Share
 0.01 0.00 0.10 0.04 0.07
Net Income Per Share
 -0.63 -0.63 -0.37 -0.54 -0.81
Tax Burden
 0.96 0.96 0.92 0.92 0.99
Interest Burden
 1.48 1.45 1.02 1.10 0.98
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.04
SG&A to Revenue
 24.33 0.00 3.35 9.63 3.86
Stock-Based Compensation to Revenue
 0.00 0.00 0.19 0.60 0.11
Income Quality
 1.24 0.00 0.77 0.77 0.73
Currency in EUR